Market Overview:
The global Orthobiologics Marketwas valued at USD 4.21 billion in 2016 and is projected to reach USD 6.51billion by 2025, growing at a CAGR of 4.96% from 2017 to 2025.
With increasing of popularity of sports and athletics, injuries associated to it are also increasing. Also, with changes in lifestyle of working class of large economy countries, problems like obesity and spinal cord disorders are becoming more prevalent. Therefore the orthobiologics market is going through a positive trend in market value.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing number of accidents and sport injuries
1.2 Growingnumber of spinal diseases and disorders
1.3 Rising number of obese citizen due to major lifestyle changes
1.4 Increase in demand of Minimally invasive processes
2. Market Restraints
2.1 High cost of complete treatment
Market Segmentation:
1. Global Orthobiologics Market, by Application:
1.1 Osteoarthritis and Degenerative Arthritis
1.2 Spinal Fusion
1.3 Soft-Tissue Injuries
1.4 Fracture Recovery
1.5 Maxillofacial and Dental Applications
2. Global Orthobiologics Market, by Product:
2.1 Viscosupplementation Products
2.2 Demineralized Bone Matrices
2.3 Synthetic Orthobiologics
2.4 Bone Morphogenic Protein
2.5 Allografts
2.6 Plasma-Rich Protein
2.7 Bone Marrow Aspirate Concentrate
3. Global Orthobiologics Market, by End User:
3.1 Hospitals, Orthopedic Clinics, & Ambulatory Care Centers
3.2 Research & Academic Institutes
4. Global Orthobiologics Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. DepuySynthes (A Subsidiary of Johnson & Johnson)
2. Medtronic PLC.
3. Stryker Corporation
4. Zimmer Biomet Holdings, Inc.
5. Harvest Technologies Corporation (A Terumo Bct Company)
6. Globus Medical, Inc.
7. Orthofix International N.V.
8. RTI Surgical, Inc.
9. K2M Group Holdings, Inc.
10. Kuros Biosciences Ltd.
11. Bioventus LLC
12. Nuvasive, Inc.
13. Seaspine Holdings Corporation
14. Arthrex, Inc.
15. Xtant Medical Holdings, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Orthobiologics Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL ORTHOBIOLOGICS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL ORTHOBIOLOGICS MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL ORTHOBIOLOGICS MARKET, BY APPLICATION
5.1 Overview
5.2 Osteoarthritis and Degenerative Arthritis
5.3 Spinal Fusion
5.4 Soft-Tissue Injuries
5.5 Fracture Recovery
5.6 Maxillofacial and Dental Applications
6 GLOBAL ORTHOBIOLOGICS MARKET, BY PRODUCT
6.1 Overview
6.2 Viscosupplementation Products
6.3 Demineralized Bone Matrices
6.4 Synthetic Orthobiologics
6.5 Bone Morphogenic Protein
6.6 Allografts
6.7 Plasma-Rich Protein
6.8 Bone Marrow Aspirate Concentrate
7 GLOBAL ORTHOBIOLOGICS MARKET, BY END USER
7.1 Overview
7.2 Hospitals, Orthopedic Clinics, & Ambulatory Care Centers
7.3 Research & Academic Institutes
8 GLOBAL ORTHOBIOLOGICS MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 â€" 2025
9 GLOBAL ORTHOBIOLOGICS MARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 DepuySynthes
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Medtronic PLC.
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Stryker Corporation
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Zimmer Biomet Holdings, Inc.
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Harvest Technologies Corporation
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Globus Medical, Inc.
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Orthofix International N.V.
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 RTI Surgical, Inc.
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 K2M Group Holdings, Inc.
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 Kuros Biosciences Ltd.
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
10.11 Bioventus LLC
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments
10.12 Nuvasive, Inc.
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Developments
10.13 Seaspine Holdings Corporation
10.13.1 Overview
10.13.2 Financial Performance
10.13.3 Product Outlook
10.13.4 Key Developments
10.14 Arthrex, Inc.
10.14.1 Overview
10.14.2 Financial Performance
10.14.3 Product Outlook
10.14.4 Key Developments
10.15 Xtant Medical Holdings, Inc.
10.15.1 Overview
10.15.2 Financial Performance
10.15.3 Product Outlook
10.15.4 Key Developments
11 Appendix
11.1 Related Reports
The global Orthobiologics market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field...
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Orthobiologics Report by Material, Application, and Geography - Global Forecast to 2027 is a professional and comprehensive research report on the world's major regional market conditions, focusi...
Overview of the Global Orthobiologics Market:The report discusses everything a marketer requires before investing in the global Orthobiologics Market during the forecast period 2022-2029. It provides detailed insight into current trends, market shares, market size, and sal...
The Orthobiologics Market is predicted to reach US$ 9.66 billion by 2031 from US$ 5.44 billion in 2020, and to grow at a CAGR of ~5.4% between the forecast period 2021 to 2031.
The research report includes specific segments by Products/Type and by Application, by region (country). T...
Overview of the Global Orthobiologics Market:
The report discusses everything a marketer requires before investing in the global Orthobiologics Market during the forecast period 2021-2028. It provides detailed insig...
Summary
HeyReport estimates that the Orthobiologics market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year considered for this report is 2019, and the market forecast is projected from 2021 to 2025.
In this repo...
The research team projects that the Orthobiologics market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.
The prime objective of this report is to help the user un...
Summary
HeyReport estimates that the Orthobiologics market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year considered for this report is 2019, and the market forecast is projected from 2021 to 2025.
In this repo...
Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use...
Summary
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
The report includes as follows:
...